一例伴有嗜酸性粒细胞增多和FIP1L1::PDGFRA重排的髓系/淋系肿瘤的疑难诊断。 - Suppr

Suppr

超能文献

A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement.

作者信息

Coltro Giacomo, Santi Raffaella

机构信息

University of Florence.

Azienda Ospedaliero-Universitaria Careggi.

出版信息

Blood. 2023 May 18;141(20):2541. doi: 10.1182/blood.2022019573.

DOI:10.1182/blood.2022019573

PMID:37200055

Abstract

摘要

相似文献

A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement.

Blood. 2023 May 18;141(20):2541. doi: 10.1182/blood.2022019573.

Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.

Am J Hematol. 2016 Mar;91(3):E10-1. doi: 10.1002/ajh.24273. Epub 2016 Jan 11.

Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm.

Leuk Lymphoma. 2020 Sep;61(9):2226-2229. doi: 10.1080/10428194.2020.1759052. Epub 2020 May 4.

Myeloid neoplasms with eosinophilia and FIP1L1-PDGFRA fusion gene: another point of view.

Leuk Lymphoma. 2013 Apr;54(4):897-8. doi: 10.3109/10428194.2012.731601. Epub 2012 Oct 26.

Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.

Pediatr Blood Cancer. 2010 Oct;55(4):730-2. doi: 10.1002/pbc.22655.

Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report.

Ann Hematol. 2024 Jan;103(1):357-360. doi: 10.1007/s00277-023-05485-y. Epub 2023 Sep 30.

Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation.

Acta Haematol. 2018;140(2):67-70. doi: 10.1159/000492485. Epub 2018 Sep 5.

A case of myeloid neoplasm with FIP1L1-PDGFRA rearrangement without marked peripheral blood eosinophilia.

Pharmacogenomics. 2016;17(2):99-102. doi: 10.2217/pgs.15.159. Epub 2015 Dec 15.

FIP1L1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case report.

Cancer Rep (Hoboken). 2023 Jan;6(1):e1769. doi: 10.1002/cnr2.1769. Epub 2022 Dec 14.

Myeloid Neoplasm With Eosinophilia and FIP1L1-PDGFRA Rearrangement Treated With Imatinib Mesylate: A Pediatric Case With Long-term Follow-up.

J Pediatr Hematol Oncol. 2019 May;41(4):334-335. doi: 10.1097/MPH.0000000000001446.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement.

作者信息

Coltro Giacomo, Santi Raffaella

机构信息

University of Florence.

Azienda Ospedaliero-Universitaria Careggi.

出版信息

Blood. 2023 May 18;141(20):2541. doi: 10.1182/blood.2022019573.

DOI:10.1182/blood.2022019573

PMID:37200055

Abstract

摘要

相似文献

A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement.

Blood. 2023 May 18;141(20):2541. doi: 10.1182/blood.2022019573.

Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.

Am J Hematol. 2016 Mar;91(3):E10-1. doi: 10.1002/ajh.24273. Epub 2016 Jan 11.

Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm.

Leuk Lymphoma. 2020 Sep;61(9):2226-2229. doi: 10.1080/10428194.2020.1759052. Epub 2020 May 4.

Myeloid neoplasms with eosinophilia and FIP1L1-PDGFRA fusion gene: another point of view.

Leuk Lymphoma. 2013 Apr;54(4):897-8. doi: 10.3109/10428194.2012.731601. Epub 2012 Oct 26.

Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.

Pediatr Blood Cancer. 2010 Oct;55(4):730-2. doi: 10.1002/pbc.22655.

Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report.

Ann Hematol. 2024 Jan;103(1):357-360. doi: 10.1007/s00277-023-05485-y. Epub 2023 Sep 30.

Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation.

Acta Haematol. 2018;140(2):67-70. doi: 10.1159/000492485. Epub 2018 Sep 5.

A case of myeloid neoplasm with FIP1L1-PDGFRA rearrangement without marked peripheral blood eosinophilia.

Pharmacogenomics. 2016;17(2):99-102. doi: 10.2217/pgs.15.159. Epub 2015 Dec 15.

FIP1L1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case report.

Cancer Rep (Hoboken). 2023 Jan;6(1):e1769. doi: 10.1002/cnr2.1769. Epub 2022 Dec 14.

Myeloid Neoplasm With Eosinophilia and FIP1L1-PDGFRA Rearrangement Treated With Imatinib Mesylate: A Pediatric Case With Long-term Follow-up.

J Pediatr Hematol Oncol. 2019 May;41(4):334-335. doi: 10.1097/MPH.0000000000001446.